Please provide your email address to receive an email when new articles are posted on . Osteochondral allograft transplantation of the patellofemoral joint yielded high return to sport rates in ...

Please provide your email address to receive an email when new articles are posted on . Data showed 84% graft survival in the patellofemoral compartment for osteochondral allograft transplantation.

Dr. Geier is an orthopedic surgeon and Director of MUSC Sports Medicine. He also serves as chairman of the Public Relations Committee for the American Orthopaedic Society for Sports Medicine.

CENTENNIAL, Colo., June 29, 2023 /PRNewswire/ -- AlloSource ®, a leading innovator and manufacturer of cartilage for joint preservation, today announced the Journal of Orthopaedic Surgery published ...

ROSEMONT, Ill., Feb. 7, 2025 /PRNewswire/ -- The 2025 Orthopaedic Research and Education Foundation (OREF) Clinical Research Award was presented to Brian J. Cole, MD, MBA, FAAOS, for his collaborative ...

"The operation went very well and the patient was discharged the same day with very little postoperative discomfort," said Dr. Nick Smith. "Having access to a cartilage allograft like ProChondrix CR ...

CENTENNIAL, Colo., April 5, 2022 /PRNewswire/ -- AlloSource®, one of the largest allograft providers creating innovative cellular and tissue allografts to help surgeons heal their patients, today ...

Epibone Inc. has received IND clearance from the FDA to begin testing its engineered allogenic osteochondral graft in humans. Clinical trials are set to open patient recruitment as soon as early next ...